Mouse Anti-COL7A1 Recombinant Antibody (0.N.229) (CBMAB-C0011-LY)

Mouse

Human, Cattle, Monkey, Pig, Sheep

0.N.229

IgG1, κ

ELISA, IF, IHC

Insoluble fractions of human neonatal foreskin epidermal cells

Human, Cattle, Monkey, Pig, Sheep

IgG1, κ

Monoclonal

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Liquid

0.2% BSA

0.09% sodium azide

0.2 mg/ml

> 95% Purity determined by SDS-PAGE.

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Collagen Type VII Alpha 1 Chain

COL7A1 (Collagen Type VII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL7A1 include Transient Bullous Dermolysis Of The Newborn and Epidermolysis Bullosa Dystrophica, Pretibial. Among its related pathways are Integrin Pathway and ERK Signaling. Gene Ontology (GO) annotations related to this gene include identical protein binding and serine-type endopeptidase inhibitor activity.
An important paralog of this gene is COL14A1.

Collagen Type VII Alpha 1 Chain; LC Collagen; Collagen VII, Alpha-1 Polypeptide; Collagen, Type VII, Alpha 1; Long-Chain Collagen; Epidermolysis Bullosa, Dystrophic, Dominant And Recessive;

Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen.

Cell adhesion Source: UniProtKB-KW
Collagen fibril organization Source: Reactome
COPII vesicle coating Source: Reactome
Endodermal cell differentiation Source: UniProtKB
Endoplasmic reticulum to Golgi vesicle-mediated transport Source: Reactome
Epidermis development Source: ProtInc
Extracellular matrix organization Source: Reactome

Basement membrane

Epidermolysis bullosa acquisita (EBA) is an autoimmune acquired blistering skin disease resulting from autoantibodies to type VII collagen.
Epidermolysis bullosa dystrophica, autosomal dominant (DDEB):
A group of autosomal dominant blistering skin diseases characterized by tissue separation which occurs below the dermal-epidermal basement membrane at the level of the anchoring fibrils. Various clinical types with different severity are recognized, ranging from severe mutilating forms to mild forms with limited and localized scarring, and less frequent extracutaneous manifestations.
Epidermolysis bullosa dystrophica, autosomal recessive (RDEB):
A group of autosomal recessive blistering skin diseases characterized by tissue separation which occurs below the dermal-epidermal basement membrane at the level of the anchoring fibrils. Various clinical types with different severity are recognized, ranging from severe mutilating forms, such as epidermolysis bullosa dystrophica Hallopeau-Siemens type, to mild forms with limited localized scarring and less frequent extracutaneous manifestations. Mild forms include epidermolysis bullosa mitis and epidermolysis bullosa localisata.
Transient bullous dermolysis of the newborn (TBDN):
TBDN is a neonatal form of dystrophic epidermolysis bullosa characterized by sub-epidermal blisters, reduced or abnormal anchoring fibrils at the dermo-epidermal junction, and electron-dense inclusions in keratinocytes. TBDN heals spontaneously or strongly improves within the first months and years of life.
Epidermolysis bullosa dystrophica, pretibial type (PR-DEB):
A form of dystrophic epidermolysis bullosa characterized by pretibial blisters that develop into prurigo-like hyperkeratotic lesions. It predominantly affects the pretibial areas, sparing the knees and other parts of the skin. Other clinical features include nail dystrophy, albopapuloid skin lesions, and hypertrophic scars without pretibial predominance. The phenotype shows considerable interindividual variability. Inheritance is autosomal dominant.
Epidermolysis bullosa dystrophica, Bart type (B-DEB):
An autosomal dominant form of dystrophic epidermolysis bullosa characterized by congenital localized absence of skin, skin fragility and deformity of nails.
Epidermolysis bullosa pruriginosa (EBP):
A distinct clinical subtype of epidermolysis bullosa dystrophica. It is characterized by skin fragility, blistering, scar formation, intense pruritus and excoriated prurigo nodules. Onset is in early childhood, but in some cases is delayed until the second or third decade of life. Inheritance can be autosomal dominant or recessive.
Nail disorder, non-syndromic congenital, 8 (NDNC8):
A nail disorder characterized by isolated toenail dystrophy. The nail changes are most severe in the great toes and consist of the nail plate being buried in the nail bed with a deformed and narrow free edge.
Epidermolysis bullosa dystrophica, with subcorneal cleavage (EBDSC):
A bullous skin disorder with variable sized clefts just beneath the level of the stratum corneum. Clinical features include blisters, milia, atrophic scarring, nail dystrophy, and oral and conjunctival involvement, as seen in dystrophic epidermolysis bullosa.

Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.